Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0343 | 0.1429 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0343 | 0.1429 | 0.1429 |
Onchocerca volvulus | 0.0343 | 0.1429 | 1 | |
Brugia malayi | Trypsin family protein | 0.0343 | 0.1429 | 1 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0894 | 1 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.0713 | 0.7175 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0252 | 0 | 0.5 |
Schistosoma mansoni | P2X receptor subunit | 0.0894 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0343 | 0.1429 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0894 | 1 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0894 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0252 | 0 | 0.5 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0252 | 0 | 0.5 |
Toxoplasma gondii | PAN domain-containing protein | 0.0713 | 0.7175 | 1 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0252 | 0 | 0.5 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0894 | 1 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0894 | 1 | 1 |
Onchocerca volvulus | 0.0275 | 0.0359 | 0.2514 | |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0894 | 1 | 1 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0894 | 1 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0343 | 0.1429 | 0.1429 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0894 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.491 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.